Ledger.Open graph →
SEC Form D · Amendment · filed February 24, 2017

Lung Therapeutics, Inc

Offering
$17.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Austin, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Aaron B. Fletcher · Carrollton, TXDirectorRobert B. Mills · Naples, FLDirectorSteven B. Idell · Tyler, TXDirectorJames B. Windsor · Austin, TXExec · DirectorCatherine Bingham · London, United KingdomDirectorKathryn Stewart · LARKSPUR, CADirectorHamish Cameron · London, United KingdomDirectorMichael Ross · London, United KingdomExec · DirectorMark Schulman · Greenwood Village, CODirectorTimothy Chklovski · Los Angeles, CADirectorAlberto Siblesz · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗